Guru Ownership Trend
Guru Analysis for Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. (APLS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $312.14 M.
Top institutional holders include Steven Cohen and George Soros.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $143.38 M net inflow during the quarter.
Recent activity highlights Jefferies Group who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 81.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Apellis Pharmaceuticals, Inc. (APLS)
Major holders include Steven Cohen ($168.32 M), George Soros ($42.48 M), Renaissance Technologies (RenTech) ($37.65 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 7.61 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $143.38 M, with 6 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited APLS. The total reported sell value was $82.36 M.
Yes, 2 managers opened new positions in APLS, and 4 increased their existing holdings. The total reported buy value was $225.75 M.
